Johnson & Johnson has secured an expanded indication from FDA for its TRUFILL n‑BCA Liquid Embolic System for embolization of the middle meningeal artery for the treatment of symptomatic subacute and ...
MMA embolization procedures to treat SDH increased significantly, from 4,014 in 2019 to 20,836 in 2023, representing a 51% compound annual growth rate. By 2030, it is expected to surpass the annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results